HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Mergui-Roelvink Selected Research

Platinum

9/2015Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Mergui-Roelvink Research Topics

Disease

4Neoplasms (Cancer)
01/2017 - 11/2011
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
09/2015
1Hand-Foot Syndrome
09/2015
1Liver Failure
09/2015
1Hypertension (High Blood Pressure)
11/2011
1Atrial Flutter (Flutter, Atrial)
11/2011

Drug/Important Bio-Agent (IBA)

2eribulinFDA Link
04/2013 - 12/2012
1QuinolonesIBA
01/2017
1vosaroxinIBA
01/2017
1Pharmaceutical PreparationsIBA
09/2015
1PlatinumIBA
09/2015
1Topotecan (Hycamtin)FDA LinkGeneric
09/2015
1taxaneIBA
04/2013
1Ketoconazole (Nizoral)FDA LinkGeneric
04/2013
1Lipase (Acid Lipase)FDA Link
11/2011
1Tyrosine Kinase InhibitorsIBA
11/2011
1Bevacizumab (Avastin)FDA Link
11/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2011
1telatinibIBA
11/2011

Therapy/Procedure

1Intravenous Injections
01/2017